Call To Action! Protect & Expand U.S. Federal Ovarian Cancer Research Funding

Do you live in AL, CA, HI, IL, IA, KS, KY, MD, MI, MO, NH, ND, PA, TX, UT, VT, WA or WI? If so, one of your Senators sits on the U.S. Senate Defense Appropriations subcommittee that determines how much funding is given to the Department of Defense Ovarian Cancer Research Program. Ask your Senator to increase funding for this critical ovarian cancer research program. Click on the hyperlink below to obtain step-by-step instructions provided by the Ovarian Cancer National Alliance. It’s so important, and it’s so easy!

Woody Allen once said that 80% of success in life is just showing up. When it comes to U.S. federal funding of ovarian cancer research on Capitol Hill, decision are definitely made by those who show up.

Do you live in Alabama, California, Hawaii, Illinois, Indiana, Kansas, Kentucky, Maryland, Michigan, Mississippi, Missouri, New Hampshire, North Dakota, Pennsylvania, Texas, Utah, Vermont, Washington, or Wisconsin?

If so, you live in a state represented by a Senator who sits on the U.S. Senate Defense Appropriations subcommittee, the subcommittee that controls spending levels for the Department of Defense Ovarian Cancer Research Program (DoD OCRP). This critical program is the only dedicated federal budget line item that funds ovarian cancer research. Last year, funding for the program was cut. We need your Senator to support this program.

Please call your Senator’s office and request that he or she talk to the Chairman or Vice-Chair of the Defense Appropriations Subcommittee to express their support of a minimum of $30 million for the DoD OCRP in 2011.

The Ovarian Cancer National Alliance makes taking this action simple! CLICK HERE , enter your zip code, and you will receive step-by-step instructions.

If your Senator gets enough calls, he or she will believe that this is an important issue and will be more inclined to have this conversation with the Chairman or Vice Chairman. Both the Chairman and the Vice-Chair play a key role in determining how much money the DoD OCRP receives in order to carry out ovarian cancer research, so it is important that they hear from their Senate colleagues.

As seen in the chart below, ovarian cancer research funded by the U.S. federal government makes up the majority of all ovarian cancer research conducted in the U.S. We need to protect and expand this funding so we can get an early detection test and more effective treatments.

Source: Ovarian Cancer National Alliance

The more calls we make, the bigger impact we will make. Get your friends and family in your state involved in the mission to get increased U.S. federal funding for ovarian cancer research by asking them to call too!

Please place your calls by September 10th!

Source:  Call to action! Protect and expand ovarian cancer research funding! Action Alert, Ovarian Cancer National Alliance.

2 thoughts on “Call To Action! Protect & Expand U.S. Federal Ovarian Cancer Research Funding

  1. Thank you for your passionate advocacy! It is greatly appreciated.
    Michael Seiden MD PhD
    CEO Fox Chase Cancer Center
    Chairman-Elect, Integration Panel, Ovarian Cancer Research Program, Congressionally Directed Medically Research Program, DOD


    • Dear Dr. Seiden:

      Thank you so much for the kind words. We want to wish you great success on the OCRP Integration Panel, and thank you for your service in that capacity. As you undoubtedly know, the federally funded Ovarian Cancer Research Program is critical to groundbreaking ovarian cancer research. If there is anything that Libby’s H*O*P*E* can do to assist your critical work, please do not hesitate to contact me.

      Also, I want you to know that my 26-year old cousin, Elizabeth Remick (to whom the website is dedicated), received a second opinion from Fox Chase during her recurrent ovarian cancer treatment. During that appointment, she met with Dr. George Coukos and was very impressed by him.

      I have also taken the liberty of providing you with a hyperlink to an article that I wrote today regarding the discover of frequent ARID1A gene mutations in endometriosis-associated cancer. The article contains citations to research work that was performed by Fox Chase with respect to clear-cell epithelial ovarian cancer.

      Best Regards,

      Paul Cacciatore
      Founder, Libby’s H*O*P*E*


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s